Veru

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Veru and other ETFs, options, and stocks.

About VERU

Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The company’s drug development program includes two late-stage novel small molecules, enobosarm and sabizabulin.

CEO

Mitchell Shuster Steiner

CEOMitchell Shuster Steiner

Employees

210

Employees210

Headquarters

Miami, Florida

HeadquartersMiami, Florida

Founded

1971

Founded1971

Employees

210

Employees210

VERU Key Statistics

Market cap

76.60M

Market cap76.60M

Price-Earnings ratio

-2.37

Price-Earnings ratio-2.37

Dividend yield

—

Dividend yield—

Average volume

931.94K

Average volume931.94K

High today

$0.5299

High today$0.5299

Low today

$0.5032

Low today$0.5032

Open price

$0.5032

Open price$0.5032

Volume

800.10K

Volume800.10K

52 Week high

$1.50

52 Week high$1.50

52 Week low

$0.45

52 Week low$0.45

People also own

Based on the portfolios of people who own VERU. This list is generated using Robinhood data, and it’s not a recommendation.